Chemours Co Stock Price, News & Analysis

Chemours (NYSE: CC) reported Q3 2025 net sales of $1.5B (flat YoY) and net income of $60M or $0.40 per diluted share versus a loss year-ago. Adjusted EBITDA was $195M versus $202M a year earlier. Key segment drivers included TSS Opteon™ revenue up 80% YoY and TSS Adjusted EBITDA of $194M (+40% YoY).

TT Adjusted EBITDA fell to $25M (down 68% YoY) and APM Adjusted EBITDA fell to $14M with outage-related costs ~$20M. Net debt was $3.6B (gross debt $4.2B) and net leverage ~4.6x. Q4 2025 guidance: consolidated Adjusted EBITDA $130–160M and sequential net sales down 10–15%.

Chemours (NYSE: CC) declared a quarterly cash dividend of $0.0875 per share for Q4 2025.

The dividend will be paid on December 15, 2025 to holders of record at the close of business on November 14, 2025.

Chemours (NYSE: CC) expects to release its third quarter 2025 financial results after market close on Thursday, November 6, 2025. Management plans a public conference call and webcast at 8:00 a.m. Eastern Time on Friday, November 7, 2025 to discuss results.

Prior to the call, prepared financial remarks will be posted in the Events and Presentations section of the Investor Relations website at investors.chemours.com. A live webcast link, accompanying slides, and a replay will be available on the same site.

Chemours (NYSE:CC) has announced key Board leadership changes effective September 2, 2025. Mary Cranston, a director since 2015, has been appointed as Chair of the Board, while Alister Cowan has been named Lead Independent Director. These appointments follow Dawn Farrell's departure to lead Canada's Major Projects Office.

Cranston, who led Chemours' Board refresh, brings extensive governance experience from serving on boards of global companies including Visa, McAfee, and TPG. Cowan, appointed to the Board in 2023, brings over 30 years of financial executive experience and chairs the Audit, Risk, and Finance Committee. The new leadership structure will focus on executing Chemours' Pathway to Thrive strategy.

Chemours (NYSE: CC) has released its 2024 Sustainability Report, highlighting significant progress towards its Corporate Responsibility Commitment (CRC) goals. The company achieved a 76% reduction in fluorinated organic chemical emissions since 2018, a 52% reduction in Scope 1 and 2 greenhouse gas emissions, and reached its 2030 Sustainable Offerings goal six years early with 50% of revenue now coming from products contributing to UN Sustainable Development Goals.

Under new CEO Denise Dignam's leadership, Chemours introduced sustainable innovations including liquid cooling solutions for data centers that can reduce cooling energy use by up to 90% and advanced EV battery binders that can reduce manufacturing footprint by 75% and energy consumption by approximately 47%.

Chemours (NYSE: CC) has announced strategic agreements with SRF Limited to strengthen its global supply chain for fluoropolymers and fluoroelastomers by 2026. The collaboration leverages SRF's manufacturing capabilities in India to produce essential materials used in semiconductor, automotive, aerospace, chemical processing, and oil and gas industries.

The partnership aligns with Chemours' Pathway to Thrive strategy, focusing on higher-value applications while requiring no upfront capital investment. The agreement will enhance Chemours' operational flexibility and ensure reliable product supply for customers worldwide by combining SRF's manufacturing excellence with Chemours' product technology and quality standards.

Chemours (NYSE:CC) announced that Samsung Electronics has successfully qualified its Opteon™ two-phase immersion cooling fluid for use with Samsung's generation four Solid State Drive (SSD). This marks a significant milestone as Opteon™ becomes the first two-phase immersion cooling fluid approved by Samsung.

The qualification process involved collaboration with Liquid Stack and PKI Corporation, utilizing a commercial scale 48U immersion cooling tank. The technology demonstrates impressive efficiency metrics, including 40% lower energy consumption, 90% reduction in cooling energy use, and 60% reduced space requirements while nearly eliminating water usage.

Samsung has developed a proprietary high-reliability test standard based on Open Compute Project (OCP) standards, which Opteon™ successfully passed. Testing for subsequent SSD generations will commence in the coming months.

Chemours (NYSE:CC) reported Q2 2025 financial results with Net Sales of $1.6 billion, up 4% year-over-year. The company posted a Net Loss of $381 million ($2.54 per diluted share), compared to Net Income of $60 million in Q2 2024, primarily due to litigation-related charges from the New Jersey settlement.

Key highlights include Adjusted EBITDA of $253 million, up 22% from prior year, driven by strong performance across segments. The Thermal & Specialized Solutions segment saw 65% growth in Opteon™ Refrigerants. The company reached a settlement with New Jersey for environmental claims, including PFAS, with payments over 25 years valued at approximately $250 million.

For Q3 2025, Chemours expects Net Sales to decrease 4-6% sequentially with Adjusted EBITDA projected between $175-195 million. Full-year 2025 guidance projects Net Sales of $5.9-6.0 billion and Adjusted EBITDA of $775-825 million.

Chemours (NYSE: CC) has scheduled its second quarter 2025 earnings release and conference call. The company will release its Q2 2025 financial results after market close on Tuesday, August 5, 2025.

The earnings conference call will be held at 8:00 a.m. Eastern Daylight Time on Wednesday, August 6, 2025. Management will post additional prepared financial remarks in the "Events and Presentations" section of the company's investor relations website before the call. The webcast will be accessible to the public through the company's investor relations website at investors.chemours.com.